United States Epilepsy Drugs Market Report 2016

December 2016 | 95 pages | ID: U269AB06941EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Epilepsy Drugs

Revenue, means the sales value of Epilepsy Drugs

This report studies sales (consumption) of Epilepsy Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GlaxoSmithKline
• Pfizer
• UCB
• Eisai
• Roche
• Shire
• Sunovion Pharmaceuticals
• Supernus Pharmaceuticals
• Upsher-Smith
• Valeant Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Epilepsy Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Epilepsy Drugs Market Report 2016

1 EPILEPSY DRUGS OVERVIEW

1.1 Product Overview and Scope of Epilepsy Drugs
1.2 Classification of Epilepsy Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Epilepsy Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Epilepsy Drugs (2011-2021)
  1.4.1 United States Epilepsy Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Epilepsy Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES EPILEPSY DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Epilepsy Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Epilepsy Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Epilepsy Drugs Average Price by Manufactures (2015 and 2016)
2.4 Epilepsy Drugs Market Competitive Situation and Trends
  2.4.1 Epilepsy Drugs Market Concentration Rate
  2.4.2 Epilepsy Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES EPILEPSY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Epilepsy Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Epilepsy Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Epilepsy Drugs Price by Type (2011-2016)
3.4 United States Epilepsy Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES EPILEPSY DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Epilepsy Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Epilepsy Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES EPILEPSY DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 GlaxoSmithKline
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Epilepsy Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GlaxoSmithKline Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Pfizer
  5.2.2 Epilepsy Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pfizer Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 UCB
  5.3.2 Epilepsy Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 UCB Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Eisai
  5.4.2 Epilepsy Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Eisai Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Roche
  5.5.2 Epilepsy Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Roche Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Shire
  5.6.2 Epilepsy Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Shire Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Sunovion Pharmaceuticals
  5.7.2 Epilepsy Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Sunovion Pharmaceuticals Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Supernus Pharmaceuticals
  5.8.2 Epilepsy Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Supernus Pharmaceuticals Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Upsher-Smith
  5.9.2 Epilepsy Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Upsher-Smith Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Valeant Pharmaceuticals
  5.10.2 Epilepsy Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Valeant Pharmaceuticals Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 EPILEPSY DRUGS MANUFACTURING COST ANALYSIS

6.1 Epilepsy Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Epilepsy Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Epilepsy Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Epilepsy Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES EPILEPSY DRUGS MARKET FORECAST (2016-2021)

10.1 United States Epilepsy Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Epilepsy Drugs Sales Forecast by Type (2016-2021)
10.3 United States Epilepsy Drugs Sales Forecast by Application (2016-2021)
10.4 Epilepsy Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Epilepsy Drugs
Table Classification of Epilepsy Drugs
Figure United States Sales Market Share of Epilepsy Drugs by Type in 2015
Table Application of Epilepsy Drugs
Figure United States Sales Market Share of Epilepsy Drugs by Application in 2015
Figure United States Epilepsy Drugs Sales and Growth Rate (2011-2021)
Figure United States Epilepsy Drugs Revenue and Growth Rate (2011-2021)
Table United States Epilepsy Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Epilepsy Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Epilepsy Drugs Sales Share by Manufacturers
Figure 2016 Epilepsy Drugs Sales Share by Manufacturers
Table United States Epilepsy Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Epilepsy Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Epilepsy Drugs Revenue Share by Manufacturers
Table 2016 United States Epilepsy Drugs Revenue Share by Manufacturers
Table United States Market Epilepsy Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Epilepsy Drugs Average Price of Key Manufacturers in 2015
Figure Epilepsy Drugs Market Share of Top 3 Manufacturers
Figure Epilepsy Drugs Market Share of Top 5 Manufacturers
Table United States Epilepsy Drugs Sales by Type (2011-2016)
Table United States Epilepsy Drugs Sales Share by Type (2011-2016)
Figure United States Epilepsy Drugs Sales Market Share by Type in 2015
Table United States Epilepsy Drugs Revenue and Market Share by Type (2011-2016)
Table United States Epilepsy Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Epilepsy Drugs by Type (2011-2016)
Table United States Epilepsy Drugs Price by Type (2011-2016)
Figure United States Epilepsy Drugs Sales Growth Rate by Type (2011-2016)
Table United States Epilepsy Drugs Sales by Application (2011-2016)
Table United States Epilepsy Drugs Sales Market Share by Application (2011-2016)
Figure United States Epilepsy Drugs Sales Market Share by Application in 2015
Table United States Epilepsy Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Epilepsy Drugs Sales Growth Rate by Application (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Epilepsy Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Epilepsy Drugs Sales Market Share (2011-2016)
Table UCB Basic Information List
Table UCB Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table UCB Epilepsy Drugs Sales Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Epilepsy Drugs Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Epilepsy Drugs Sales Market Share (2011-2016)
Table Shire Basic Information List
Table Shire Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Epilepsy Drugs Sales Market Share (2011-2016)
Table Sunovion Pharmaceuticals Basic Information List
Table Sunovion Pharmaceuticals Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sunovion Pharmaceuticals Epilepsy Drugs Sales Market Share (2011-2016)
Table Supernus Pharmaceuticals Basic Information List
Table Supernus Pharmaceuticals Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Supernus Pharmaceuticals Epilepsy Drugs Sales Market Share (2011-2016)
Table Upsher-Smith Basic Information List
Table Upsher-Smith Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Upsher-Smith Epilepsy Drugs Sales Market Share (2011-2016)
Table Valeant Pharmaceuticals Basic Information List
Table Valeant Pharmaceuticals Epilepsy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Pharmaceuticals Epilepsy Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Epilepsy Drugs
Figure Manufacturing Process Analysis of Epilepsy Drugs
Figure Epilepsy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Epilepsy Drugs Major Manufacturers in 2015
Table Major Buyers of Epilepsy Drugs
Table Distributors/Traders List
Figure United States Epilepsy Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Epilepsy Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Epilepsy Drugs Production Forecast by Type (2016-2021)
Table United States Epilepsy Drugs Consumption Forecast by Application (2016-2021)